國立高雄大學圖資館 |

登入

回首頁

In vitro diagnostic industry in China

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	In vitro diagnostic industry in Chinaedited by Haibo Song, Lizhong Dai.
其他作者:	Song, Haibo.
出版者:	Singapore :Springer Nature Singapore :2023.
面頁冊數:	xi, 605 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Diagnosis, LaboratoryChina.
電子資源:	https://doi.org/10.1007/978-981-99-3110-1
ISBN:	9789819931101$q(electronic bk.)

In vitro diagnostic industry in China
In vitro diagnostic industry in China[electronic resource] /edited by Haibo Song, Lizhong Dai. - Second edition. - Singapore :Springer Nature Singapore :2023. - xi, 605 p. :ill., digital ;24 cm.

Current Status and Progress -- Opportunities and Challenges -- Chemiluminescence Instruments and Reagents -- Fully automated enzyme immunological instruments and related instruments -- Autoimmune Diagnostics -- Tumor Markers -- ELISA Immunological Reagents -- Biochemical Analytical Instruments and Reagents -- Electrolyte Analysis Techniques -- Blood Gas Analysis Techniques -- Biochemical Assembly Lines -- Molecular Diagnosis of Novel Coronavirus -- Molecular Diagnostic Analyzers and Reagents -- Overview -- Domestic and Foreign Real-time Detection Market Situation -- Major Domestic Manufacturers -- Hemagglutination instruments and reagents -- Blood Group Detection Instruments and Supporting Reagents -- Urine -- Stool and Intestinal Microecology Testing -- Semen -- Vaginal Discharge -- Blood Cell Analyzers and Reagents -- Microbial Culture Analyzers and Reagents -- Concomitant Diagnosis -- Flight Mass Spectrometry Techniques -- Tandem Mass Spectrometry -- Overview of Pathological Diagnosis -- Routine Pathology -- Cytopathology -- Immunohistochemistry -- Molecular Pathology -- Numeral Pathology -- Classification and Status of Raw Materials for In Vitro Diagnostics -- Bottlenecks and Favorable Factors for the Development of Raw Materials for In Vitro Diagnostic Reagents -- Development and Application status of National Reference Materials for In Vitro Diagnostic Reagents -- Research and Development, Production, and Application status of quality controls for in vitro diagnostic reagents -- 2021 Results of Listed Companies -- Investment and Financing Mergers and Acquisitions of Listed Companies in 2021.

This book systematically describes the achievements and current situation of in vitro diagnostic (IVD) industry in China. It consists of twelve parts, including the overview on the IVD industry in China in 2021, hot technologies and products of IVD industry, academic, technological and product development in the field of IVD, such as biochemical diagnosis, immune-diagnosis, point-of-care testing, molecular diagnosis, blood and body fluid diagnosis, laboratory assembly line, etc. In this second edition, the new contents added include the development of new coronavirus molecular diagnostic products, flight mass spectrometry, tandem mass spectrometry, tumor markers, ELISA immune reagents, autoimmune diagnostics, concomitant diagnosis, fecal and intestinal microecology detection, pathological diagnosis, raw materials for in vitro diagnostic reagents, standard substances and quality controls for in vitro diagnostic reagents, etc., making the content of the whole book more novel and rich. This book is compiled by an editorial committee composed of well-known entrepreneurs, experts and professors in IVD industry in China. It is a reference book for practitioners of IVD industry, medical laboratory and medical staffs all over the world.

ISBN: 9789819931101$q(electronic bk.)

Standard No.: 10.1007/978-981-99-3110-1doiSubjects--Topical Terms:

901790
Diagnosis, Laboratory
--China.

LC Class. No.: RB37

Dewey Class. No.: 616.0750951

In vitro diagnostic industry in China
LDR:03859nmm a2200337 a 4500 001 653468
003 DE-He213
005 20231208190152.0
006 m d
007 cr nn 008maaau
008 240426s2023 si s 0 eng d
020 $a 9789819931101$q(electronic bk.)
020 $a 9789819931095$q(paper)
024 7 $a 10.1007/978-981-99-3110-1 $2 doi
035 $a 978-981-99-3110-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RB37
072 7 $a MJA $2 bicssc
072 7 $a MED000000 $2 bisacsh
072 7 $a MJA $2 thema
082 0 4 $a 616.0750951 $2 23
090 $a RB37 $b .I35 2023
245 0 0 $a In vitro diagnostic industry in China $h [electronic resource] / $c edited by Haibo Song, Lizhong Dai.
250 $a Second edition.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2023.
300 $a xi, 605 p. : $b ill., digital ; $c 24 cm.
505 0 $a Current Status and Progress -- Opportunities and Challenges -- Chemiluminescence Instruments and Reagents -- Fully automated enzyme immunological instruments and related instruments -- Autoimmune Diagnostics -- Tumor Markers -- ELISA Immunological Reagents -- Biochemical Analytical Instruments and Reagents -- Electrolyte Analysis Techniques -- Blood Gas Analysis Techniques -- Biochemical Assembly Lines -- Molecular Diagnosis of Novel Coronavirus -- Molecular Diagnostic Analyzers and Reagents -- Overview -- Domestic and Foreign Real-time Detection Market Situation -- Major Domestic Manufacturers -- Hemagglutination instruments and reagents -- Blood Group Detection Instruments and Supporting Reagents -- Urine -- Stool and Intestinal Microecology Testing -- Semen -- Vaginal Discharge -- Blood Cell Analyzers and Reagents -- Microbial Culture Analyzers and Reagents -- Concomitant Diagnosis -- Flight Mass Spectrometry Techniques -- Tandem Mass Spectrometry -- Overview of Pathological Diagnosis -- Routine Pathology -- Cytopathology -- Immunohistochemistry -- Molecular Pathology -- Numeral Pathology -- Classification and Status of Raw Materials for In Vitro Diagnostics -- Bottlenecks and Favorable Factors for the Development of Raw Materials for In Vitro Diagnostic Reagents -- Development and Application status of National Reference Materials for In Vitro Diagnostic Reagents -- Research and Development, Production, and Application status of quality controls for in vitro diagnostic reagents -- 2021 Results of Listed Companies -- Investment and Financing Mergers and Acquisitions of Listed Companies in 2021.
520 $a This book systematically describes the achievements and current situation of in vitro diagnostic (IVD) industry in China. It consists of twelve parts, including the overview on the IVD industry in China in 2021, hot technologies and products of IVD industry, academic, technological and product development in the field of IVD, such as biochemical diagnosis, immune-diagnosis, point-of-care testing, molecular diagnosis, blood and body fluid diagnosis, laboratory assembly line, etc. In this second edition, the new contents added include the development of new coronavirus molecular diagnostic products, flight mass spectrometry, tandem mass spectrometry, tumor markers, ELISA immune reagents, autoimmune diagnostics, concomitant diagnosis, fecal and intestinal microecology detection, pathological diagnosis, raw materials for in vitro diagnostic reagents, standard substances and quality controls for in vitro diagnostic reagents, etc., making the content of the whole book more novel and rich. This book is compiled by an editorial committee composed of well-known entrepreneurs, experts and professors in IVD industry in China. It is a reference book for practitioners of IVD industry, medical laboratory and medical staffs all over the world.
650 0 $a Diagnosis, Laboratory $z China. $3 901790
650 1 4 $a Diagnosis. $3 192756
650 2 4 $a Diseases. $3 276053
650 2 4 $a Oncology. $3 195181
650 2 4 $a Biomedical Research. $3 243625
700 1 $a Song, Haibo. $3 901788
700 1 $a Dai, Lizhong. $3 964013
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-99-3110-1
950 $a Medicine (SpringerNature-11650)